ROBO Global Robotics

Coherent Corp. Director Sells Common Shares

Financial Giants Conduct Significant Bullish Trades in Intuitive Surgical, Citigroup Downgrades Its Rating

Bain Capital's Sale of Coherent Stock Triggers Market Reassessment

Wells Fargo Raises Intuitive Surgical Target Price to $654

Nebula Cuts Stake in Teradyne, Frontier Makes Significant Increase

Rockwell VP Isaac Woods Sells Shares

Illumina Inc. partners with MyOme to advance AI-based genomic health solutions

Rockwell Automation CEO Blake Moret Sells Shares

Rebecca W. House, Vice President of Rockwell Automation, Sells Shares and Exercises Options

Rockwell Automation VP Discloses Shareholding Changes: Sold 1,654 Shares and Exercised 3,018 Shares

Intuitive Surgical Executives Dispose of Common Stock

Intuitive Surgical's Da Vinci SP System Receives FDA Approval to Expand Application Scope

Illumina Inc. Senior VP Disposes of Common Stock

Almac Group and others win 2025 Visionary Growth Leadership Best Practices Award

Teradyne Plans to Open US Operations Center by 2026

Rockwell Automation Announces Strategic Innovations in MES Product Line

Citigroup Raises Rockwell Automation's Target Price to $466

Rockwell Automation insiders sold $1.424 million worth of stocks

California Public Employees' Retirement System Increases Holdings in Intuitive Surgical

Russell Investments Substantially Reduces Holdings in Teradyne

AdvisorShares MSOS 2x Daily ETF

cbdMD

Tryhard

Roundhill Cannabis ETF

Neo-Concept

Amplify Seymour Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Canopy Growth

RYTHM

Tilray Brands

ISRG

Lazard Asset Management LLC increased its stake in Intuitive Surgical, Inc. by 0.4% in Q2, now holding 589,109 shares worth $320.13 million. Other institutional investors also adjusted their positions. Insiders sold 109,043 shares worth $60.82 million in the last 90 days. Analysts have mixed ratings on ISRG, with a consensus rating of 'Moderate Buy' and a price target of $608.79. Intuitive Surgical's Q3 earnings exceeded expectations with $2.51 billion in revenue and $2.40 EPS.

Market Beat

Lazard

Intuitive Surgical

Lazard Asset Management LLC Increases Stock Holdings in Intuitive Surgical, Inc. $ISRG

Adage Capital Partners GP L.L.C. reduced its stake in Intuitive Surgical, Inc. by 4.4% in Q2, now holding 369,584 shares worth $200.84 million. Other institutional investors like Vanguard, State Street, and Geode also adjusted their positions. Insider transactions included significant sales by EVP Brian Miller and CEO David Rosa. Intuitive Surgical reported strong Q3 earnings, with a 22.9% revenue increase. Analysts remain positive, with Royal Bank of Canada setting a $625 price target.

Adage Capital Partners GP L.L.C. Has $200.84 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

COHR

Reporter NameCorasanti Joseph JRelationshipDirector, 10% OwnerTypeSellAmount$2,951,100SEC FilingForm 4Joseph J Corasanti, a 10% owner and director of Coherent Corp, sold 15,000 shares of common stock on December 10, 2025, at a price of $196.74 per share, totaling $2,951,100. Following the transaction, Corasanti directly owns 79,914 shares of the company.SEC Filing: COHERENT CORP. [ COHR ] - Form 4 - Dec. 12, 2025

TradingView

Coherent Corp.

Coherent Corp Director Sells 15,000 Shares

Joseph J. Corasanti, Director of Coherent Corp., has sold common shares of the company. The transaction details are available via EDGAR, the SEC's system. This information is provided by Public Technologies using AI and is not financial advice.

Reuters

Coherent Corp. Director Joseph J. Corasanti Reports Sale of Common Shares

Teradyne (NASDAQ:TER) has outperformed the market over the past 15 years, achieving an average annual return of 19.24%. A $100 investment in Teradyne 15 years ago would now be worth $1,394.16, highlighting the power of compounded returns. The company's current market capitalization is $30.21 billion. This analysis underscores the significant impact of long-term investing and compounded growth.

benzinga_article

Teradyne

$100 Invested In Teradyne 15 Years Ago Would Be Worth This Much Today

Teradyne Inc.'s stock fell 5.20% to $193.37 on Friday, underperforming compared to competitors like Keysight Technologies, Fortive Corp., and Cohu Inc. The stock is 5.67% below its 52-week high of $205.00. Trading volume was higher than the 50-day average. The S&P 500 and Dow Jones also experienced declines.

Dow Jones

Teradyne Inc. Stock Underperforms Friday When Compared To Competitors

Rockwell Automation Inc. (ROK) shares fell 1.91% to $405.18 on Friday, underperforming compared to competitors. The S&P 500 Index fell 1.07% and the Dow Jones Industrial Average fell 0.51%. The stock ended a two-day winning streak and closed 2.58% below its 52-week high. Trading volume was below the 50-day average.

Rockwell Automation

Rockwell Automation Inc. Stock Underperforms Friday When Compared To Competitors

Financial giants have made significant bullish moves on Intuitive Surgical (NASDAQ:ISRG) with 9 unusual options trades. 55% of traders were bullish, targeting a price range of $300 to $600. The mean open interest is 146.5 with a total volume of 70.00. Intuitive Surgical develops robotic systems for minimally invasive surgery, with over 10,000 installations worldwide. Current stock price is $547.13, with an average target price of $635.0. Citigroup downgraded its rating to Neutral with a new price target of $635.

Smart Money Is Betting Big In ISRG Options

Bain Capital's sale of Coherent (COHR) shares has prompted investors to reassess the stock's valuation. Despite a strong 90-day return of 92.74% and a 3-year return of 471.06%, analysts suggest the stock is overvalued at $198.50, with a fair value closer to $175. Analysts' price targets vary, with a consensus at $113.368. The market's optimism contrasts with concerns over competition and demand fluctuations. Investors are encouraged to explore other high-growth tech and AI stocks.

Simplywall

Reassessing Coherent (COHR) Valuation After Bain Capital’s Third Secondary Share Sale

CEO Smith of Teradyne Inc filed a Form 144 with the SEC to sell 1,108 shares on December 12, 2025, through Fidelity Brokerage Services, under a prearranged trading plan (10b5-1).

CEO Smith Files To Sell 1,108 Of Teradyne Inc [TER]

Wells Fargo & Company raised its target price for Intuitive Surgical (NASDAQ:ISRG) from $600 to $654, maintaining an "overweight" rating, indicating a potential upside of 19.48%. Other brokerages also adjusted their price targets, with a consensus rating of "Moderate Buy" and a target price of $608.79. Intuitive Surgical reported strong quarterly earnings, beating estimates, and insiders have recently sold shares. Hedge funds have adjusted their positions in the company.

Wells Fargo & Company Issues Positive Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Nebula Research & Development LLC reduced its stake in Teradyne, Inc. by 35.8% in Q2, selling 12,067 shares. Other institutional investors adjusted their positions, with Frontier Capital Management significantly increasing its stake. CEO Gregory Smith sold 1,108 shares. Teradyne's stock opened at $203.97, with a market cap of $31.94 billion. The company reported better-than-expected Q3 earnings and announced a $0.12 quarterly dividend. Analysts have mixed ratings, with some upgrading the stock to 'buy.'

Teradyne, Inc. $TER Shares Sold by Nebula Research & Development LLC